Anti-VEGFD antibody [EPR8457] (ab155288)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR8457] to VEGFD
- Suitable for: WB, IHC-P, Flow Cyt, ICC/IF
- Reacts with: Mouse, Rat, Human
Overview
-
Product name
Anti-VEGFD antibody [EPR8457]
See all VEGFD primary antibodies -
Description
Rabbit monoclonal [EPR8457] to VEGFD -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species Flow Cyt MouseICC/IF HumanIHC-P HumanWB RatHuman -
Immunogen
-
Positive control
- Raji, HT-1080, MCF-7, and Caco-2 cell lysates. Human heart and lung tissue.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
Storage buffer
Preservative: 0.01% Sodium azide
Constituents: 40% Glycerol, 0.05% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR8457 -
Isotype
IgG -
Research areas
Images
-
ab155288 staining VEGFD in human cardiac muscle tissue sections by Immunohistochemistry (IHC-P - Formalin/paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/700. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody at a dilution of 1/500.
Negative control: PBS in place of primary antibody.
-
ab155288 staining VEGFD in MCF-7 (human breast carcinoma) cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody at a dilution of 1/200. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody. ab7291 and ab150120 were used as counterstains for primary antibody ab155288 and secondary antibody ab150077 respectively and DAPI was used as a nuclear counterstain.
Negative control 1: Rabbit primary antibody and anti-mouse secondary antibody (ab150120)
Negative control 2: Mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077) -
All lanes : Anti-VEGFD antibody [EPR8457] (ab155288) at 1/10000 dilution
Lane 1 : Raji (human Burkitt's lymphoma) whole cell lysate
Lane 2 : HT1080 (human fibrosarcoma) whole cell lysate
Lane 3 : Caco-2 (human colorectal adenocarcinoma) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Predicted band size: 40 kDa
Additional bands at: 40 kDa. We are unsure as to the identity of these extra bands.Diluting and blocking buffer: 5% NFDM/TBST
-
Anti-VEGFD antibody [EPR8457] (ab155288) at 1/10000 dilution (Unpurified) + GST-Tagged human VEGFD (aa 1 to 354) recombinant protein
Secondary
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/1000 dilution
Predicted band size: 40 kDa
Observed band size: 65 kDa why is the actual band size different from the predicted?Blocking/Diluting Buffer and concentration: 5% NFDM/TBST
-
ab155288 staining VEGFD in the mouse cell line NIH/3T3 (mouse embryo) by flow cytometry. Cells were fixed with 4% paraformaldehyde and the sample was incubated with the primary antibody at a dilution of 1/200. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/2000 was used as the secondary antibody.
Isoytype control: Rabbit monoclonal IgG (Black)
Unlabelled control: Cell without incubation with primary antibody and secondary antibody (Blue)
-
All lanes : Anti-VEGFD antibody [EPR8457] (ab155288) at 1/2000 dilution
Lane 1 : Rat lung tissue lysate
Lane 2 : NIH/3T3 (mouse embryo) whole cell lysate
Lysates/proteins at 15 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Predicted band size: 40 kDa
Additional bands at: 40 kDa. We are unsure as to the identity of these extra bands.Diluting and blocking buffer: 5% NFDM/TBST
-
All lanes : Anti-VEGFD antibody [EPR8457] (ab155288) at 1/1000 dilution
Lane 1 : Raji lysate
Lane 2 : HT-1080 lysate
Lane 3 : MCF-7 lysate
Lane 4 : Caco-2 lysate
Lysates/proteins at 10 µg per lane.
Predicted band size: 40 kDa
-
Immunohistochemical analysis of paraffin embedded Human heart tissue labeling VEGFD with ab155288 at a 1/100 dilution.
-
Immunohistochemical analysis of paraffin embedded Human lung tissue labeling VEGFD with ab155288 at a 1/100 dilution.
-
Immunohistochemical analysis of paraffin embedded Human normal kidney tissue using ab155288 showing +ve staining.
-
Immunohistochemical analysis of paraffin embedded Human skeletal muscle tissue using ab155288showing +ve staining.
-